Data-Driven Strategies for Patient Engagement About Cancer Clinical Trials
Study Overview
Status
Intervention / Treatment
Detailed Description
PRIMARY OBJECTIVE:
I. To develop a multi-level data-driven intervention to improve cancer patient engagement with cancer clinical trials.
OUTLINE: This is an observational study.
Patients review educational materials and complete surveys on study.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
California
-
Los Angeles, California, United States, 90033
- USC / Norris Comprehensive Cancer Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
Eligible patient participants will be:
- Black/African American, Asian/Asian American, White or Hispanic adults of any gender 21 years of age or older. Race/ethnicity will be self-reported
- Have been diagnosed any cancer type
Exclusion Criteria:
Participants (patients) will be excluded if they:
- Are unable to give informed consent
- Are unable to speak English or Spanish
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Observational
Patients review educational materials and complete surveys on study.
|
Non-interventional study
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Baseline Survey Score
Time Frame: Through study completion, up to 1 year
|
The survey is a validated instrument (CHEKS*) evaluated patients' knowledge and beliefs about cancer clinical trials (CCTs) before and after exposure to educational stimuli (written and video) detailing the purpose and characteristics of CCTs. The survey scores knowledge and beliefs about CCTs on a 100-point scale.The survey is collected before and after education materials are provided. The change in survey score will be analyzed. A paired t-test will be used to examine changes in CCT knowledge and Chi-Square tests of association to determine whether CCT knowledge and beliefs are associated with sociodemographic variables. *Chung A, Donley T, Hays RD, et al. Development and evaluation of the Clinical Trial HEalth Knowledge and Beliefs Scale (CHEKS). Int J Environ Res Public Health. 2022;19(14):8660. doi:10.3390/ijerph19148660 |
Through study completion, up to 1 year
|
Collaborators and Investigators
Investigators
- Principal Investigator: Chanita Hughes-Halbert, University of Southern California
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 19PS-24-2 (Other Identifier: USC / Norris Comprehensive Cancer Center)
- P30CA014089 (U.S. NIH Grant/Contract)
- NCI-2026-00806 (Registry Identifier: CTRP (Clinical Trial Reporting Program))
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.